Cost-effectiveness of azacitidine and venetoclax in unfit patients with previously untreated acute myeloid leukemia
Autor: | Patel, Kishan K. *, Zeidan, Amer M. *, Shallis, Rory M., Prebet, Thomas, Podoltsev, Nikolai, Huntington, Scott F. |
---|---|
Zdroj: | In Blood Advances 23 February 2021 5(4):994-1002 |
Databáze: | ScienceDirect |
Externí odkaz: |